LLY

970.17

-3.27%↓

JNJ

236.59

-3.81%↓

ABBV

229.41

-2.38%↓

NVS

159.59

-2.94%↓

AZN

195.92

-3.16%↓

LLY

970.17

-3.27%↓

JNJ

236.59

-3.81%↓

ABBV

229.41

-2.38%↓

NVS

159.59

-2.94%↓

AZN

195.92

-3.16%↓

LLY

970.17

-3.27%↓

JNJ

236.59

-3.81%↓

ABBV

229.41

-2.38%↓

NVS

159.59

-2.94%↓

AZN

195.92

-3.16%↓

LLY

970.17

-3.27%↓

JNJ

236.59

-3.81%↓

ABBV

229.41

-2.38%↓

NVS

159.59

-2.94%↓

AZN

195.92

-3.16%↓

LLY

970.17

-3.27%↓

JNJ

236.59

-3.81%↓

ABBV

229.41

-2.38%↓

NVS

159.59

-2.94%↓

AZN

195.92

-3.16%↓

Inicio・Lista de Acciones・CorMedix Inc

CorMedix Inc

Abierto

SectorSanidad

6.41 -10.6

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

6.11

Máximo

7.2

Métricas clave
By Trading Economics
Ingresos	89M 109M
Ventas	65M 104M
P/B Media del Sector	3.262 66.845
Margen de beneficios	104.112
Empleados	64
EBITDA	37M 57M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+97.83% upside

Dividendos
By Dow Jones
Próximas Ganancias	5 mar 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-300M 568M
Apertura anterior	17.01
Cierre anterior	6.41

Noticias sobre sentimiento de mercado

By Acuity

40%

60%

129 / 351 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

9.2 / N/A Soporte y Resistencia

CorMedix Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

4 mar 2026, 23:39 UTC

Acciones populares

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

4 mar 2026, 23:20 UTC

Ganancias

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

4 mar 2026, 21:43 UTC

Ganancias

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

4 mar 2026, 23:48 UTC

Charlas de Mercado

Nikkei May Rise After Recent Selloffs -- Market Talk

4 mar 2026, 23:33 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

4 mar 2026, 23:24 UTC

Charlas de Mercado

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

4 mar 2026, 22:30 UTC

Ganancias

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

4 mar 2026, 22:30 UTC

Ganancias

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

4 mar 2026, 22:30 UTC

Ganancias

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

4 mar 2026, 22:13 UTC

Ganancias

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

4 mar 2026, 22:13 UTC

Ganancias

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

4 mar 2026, 22:13 UTC

Ganancias

Vermilion Energy 4Q EPS C$2.86 >VET

4 mar 2026, 22:04 UTC

Charlas de Mercado

RBA Slipping Behind The Curve On Rates -- Market Talk

4 mar 2026, 21:53 UTC

Ganancias

Lithium Americas 4Q Rev $66.8M >LAC

4 mar 2026, 21:53 UTC

Ganancias

Lithium Americas 4Q Loss/Shr 52c >LAC

4 mar 2026, 21:52 UTC

Ganancias

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar 2026, 21:50 UTC

Ganancias

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

4 mar 2026, 21:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

4 mar 2026, 21:48 UTC

Ganancias

Webull 4Q Rev $165.2M >BULL

4 mar 2026, 21:48 UTC

Ganancias

Webull 4Q EPS 1c >BULL

4 mar 2026, 21:45 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

4 mar 2026, 21:45 UTC

Charlas de Mercado

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

4 mar 2026, 21:40 UTC

Ganancias

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar 2026, 21:36 UTC

Noticias de Eventos Importantes

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

4 mar 2026, 21:27 UTC

Ganancias

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar 2026, 21:17 UTC

Charlas de Mercado

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

4 mar 2026, 21:16 UTC

Ganancias

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

4 mar 2026, 21:15 UTC

Ganancias

Broadcom 1Q EPS $1.50 >AVGO

4 mar 2026, 21:15 UTC

Ganancias

Broadcom 1Q Net $7.35B >AVGO

4 mar 2026, 21:15 UTC

Ganancias

Broadcom 1Q Rev $19.31B >AVGO

Comparación entre iguales

Cambio de precio

CorMedix Inc previsión

Precio Objetivo

By TipRanks

97.83% repunte

Estimación a 12 Meses

Media 13.67 USD 97.83%

Máximo 15 USD

Mínimo 13 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CorMedix Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para CorMedix Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

9.2 / N/ASoporte y Resistencia

Recent bullish events outweigh bearish events.

All events are bullish.

Sentimiento

By Acuity

129 / 351 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.